Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : PHAT save search
LAXAI Receives Investment from SIGNET Healthcare Partners LAXAI Inc. announced that it has received a growth capital investment from SIGNET Healthcare Partners, a New York-based healthcare private equi...
Published: 2022-10-24 (Crawled : 06:00) - biospace.com/
PCVX | $60.65 -2.85% -2.93% 660K
|
Health Technology
|
| O: 70.8%
H: 2.7%
C: -6.12%
PHAT | $9.5 -3.06% -3.16% 420K
|
Health Technology
|
| O: 0.7%
H: 1.64%
C: -3.68%
growth
Phathom Pharmaceuticals Announces Regulatory Update and Plans for 2023 Erosive Esophagitis and H. pylori Commercial Launch
Published: 2023-04-04 (Crawled : 18:00) - biospace.com/
PHAT | $9.5 -3.06% -3.16% 420K
|
Health Technology
|
| O: 13.88%
H: 1.07%
C: -4.79%
update pharmaceuticals commercial
Phathom Pharmaceuticals Withdraws Public Offering
Published: 2021-10-28 (Crawled : 04:00) - globenewswire.com
PHAT | $9.5 -3.06% -3.16% 420K
|
Health Technology
|
| O: 8.84%
H: 1.37%
C: -10.06%
offering publication
Phathom Pharmaceuticals Withdraws Public Offering - Oct 28, 2021
Published: 2021-10-28 (Crawled : 09:00) - biospace.com/
PHAT | $9.5 -3.06% -3.16% 420K
|
Health Technology
|
| O: 8.84%
H: 1.37%
C: -10.06%
offering publication
Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Published: 2024-03-07 (Crawled : 13:00) - globenewswire.com
PHAT | $9.5 -3.06% -3.16% 420K
|
Health Technology
|
| O: 7.81%
H: 0.67%
C: -13.35%
business year update pharmaceuticals financial results
Phathom Pharmaceuticals to Present Data at DDW 2022 Annual Meeting
Published: 2022-05-17 (Crawled : 12:20) - globenewswire.com
PHAT | $9.5 -3.06% -3.16% 420K
|
Health Technology
|
| O: 6.5%
H: 17.95%
C: 14.5%
Phathom Pharmaceuticals to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
Published: 2024-01-31 (Crawled : 13:00) - globenewswire.com
PHAT | $9.5 -3.06% -3.16% 420K
|
Health Technology
|
| O: 4.1%
H: 1.34%
C: -5.77%
conference pharmaceuticals
Phathom Pharmaceuticals Announces FDA Approval of VOQUEZNA® (vonoprazan) Tablets for the Treatment of Erosive GERD and Relief of Heartburn Associated with Erosive GERD in Adults
Published: 2023-11-01 (Crawled : 21:00) - globenewswire.com
PHAT | $9.5 -3.06% -3.16% 420K
|
Health Technology
|
| O: 3.33%
H: 3.22%
C: -19.64%
voquezna fda approval treatment pharmaceuticals
Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
Published: 2023-04-12 (Crawled : 14:00) - biospace.com/
PHAT | $9.5 -3.06% -3.16% 420K
|
Health Technology
|
| O: 3.16%
H: 5.42%
C: 3.06%
pharmaceuticals
Phathom Pharmaceuticals Announces Positive Topline Results from PHALCON-EE Pivotal Phase 3 Erosive Esophagitis Trial
Published: 2021-10-18 (Crawled : 19:00) - biospace.com/
PHAT | $9.5 -3.06% -3.16% 420K
|
Health Technology
|
| O: 2.92%
H: 0.0%
C: -18.53%
positive results topline phase 3 trial
Phathom Pharmaceuticals Reports Third Quarter 2021 Results and Provides Key Clinical, Regulatory, and Business Updates
Published: 2021-11-08 (Crawled : 13:15) - globenewswire.com
PHAT | $9.5 -3.06% -3.16% 420K
|
Health Technology
|
| O: 2.59%
H: 0.0%
C: -2.96%
results
Phathom Pharmaceuticals Announces FDA Acceptance of NDA Resubmission for Erosive GERD
Published: 2023-06-12 (Crawled : 12:00) - globenewswire.com
PHAT | $9.5 -3.06% -3.16% 420K
|
Health Technology
|
| O: 2.54%
H: 0.45%
C: -3.15%
fda resubmission pharmaceuticals
Phathom Pharmaceuticals Provides Update on New Drug Application Review of Vonoprazan for Erosive Esophagitis
Published: 2023-01-03 (Crawled : 00:00) - biospace.com/
PHAT | $9.5 -3.06% -3.16% 420K
|
Health Technology
|
| O: 2.5%
H: 9.3%
C: 4.26%
pharmaceuticals drug application review update
Phathom Pharmaceuticals Launches Direct-to-Consumer Campaign, “VOQUEZNA Can Kick Some Acid”
Published: 2024-03-26 (Crawled : 12:00) - globenewswire.com
PHAT | $9.5 -3.06% -3.16% 420K
|
Health Technology
|
| O: 2.3%
H: 6.7%
C: -1.78%
pharmaceuticals
Phathom Pharmaceuticals Announces Plans to Initiate Vonoprazan Development Program in Non-Erosive Reflux Disease (NERD)
Published: 2020-12-14 (Crawled : 14:01) - globenewswire.com
PHAT | $9.5 -3.06% -3.16% 420K
|
Health Technology
|
| O: 2.0%
H: 2.87%
C: -4.22%
disease program
Phathom Pharmaceuticals to Present at the Bank of America Securities 2021 Virtual Healthcare Conference
Published: 2021-05-06 (Crawled : 22:00) - globenewswire.com
PHAT | $9.5 -3.06% -3.16% 420K
|
Health Technology
|
| O: 1.87%
H: 3.56%
C: 1.98%
conference
Phathom Pharmaceuticals Reports First Quarter 2023 Results
Published: 2023-05-10 (Crawled : 12:00) - globenewswire.com
PHAT | $9.5 -3.06% -3.16% 420K
|
Health Technology
|
| O: 1.83%
H: 4.42%
C: 1.8%
pharmaceuticals results
Phathom Pharmaceuticals Announces Completion of Patient Enrollment in Pivotal Phase 3 Helicobacter pylori (H. pylori) Trial
Published: 2021-01-19 (Crawled : 14:01) - globenewswire.com
PHAT | $9.5 -3.06% -3.16% 420K
|
Health Technology
|
| O: 1.6%
H: 1.49%
C: 1.02%
phase 3 trial enroll
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Allianz SE Investors with Losses to Secure Counsel Before Important Deadline in First Filed Securities Class Action Initiated by the Firm - ALIZY
Published: 2023-02-14 (Crawled : 23:00) - prnewswire.com
ROL | $42.44 -1.33% 0.0% 2M
|
Consumer Services
|
| O: -0.28%
H: 1.27%
C: 1.04%
PHAT | $9.5 -3.06% -3.16% 420K
|
Health Technology
|
| O: 1.42%
H: 16.36%
C: 8.76%
deadline initiated
DAKT FINAL DEADLINE ALERT: NATIONALLY RANKED ROSEN LAW FIRM Encourages Daktronics, Inc. Investors to Secure Counsel Before Important February 21 Deadline in Securities Class Action - DAKT
Published: 2023-02-14 (Crawled : 00:00) - prnewswire.com
PHAT | $9.5 -3.06% -3.16% 420K
|
Health Technology
|
| O: 1.42%
H: 16.36%
C: 8.76%
DAKT | $9.22 2.9% 2.82% 500K
|
Electronic Technology
|
| O: -0.98%
H: 4.68%
C: 2.96%
deadline
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.